239 related articles for article (PubMed ID: 19591931)
1. Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status.
Lønning PE; Helle H; Duong NK; Ekse D; Aas T; Geisler J
J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):31-41. PubMed ID: 19591931
[TBL] [Abstract][Full Text] [Related]
2. Recent data on intratumor estrogens in breast cancer.
Lønning PE; Haynes BP; Straume AH; Dunbier A; Helle H; Knappskog S; Dowsett M
Steroids; 2011 Jul; 76(8):786-91. PubMed ID: 21439992
[TBL] [Abstract][Full Text] [Related]
3. Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.
Saez S; Martin PM; Chouvet CD
Cancer Res; 1978 Oct; 38(10):3468-73. PubMed ID: 688231
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status.
Geisler J; Suzuki T; Helle H; Miki Y; Nagasaki S; Duong NK; Ekse D; Aas T; Evans DB; Lønning PE; Sasano H
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):237-41. PubMed ID: 19883757
[TBL] [Abstract][Full Text] [Related]
5. Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level.
Drafta D; Prişcu A; Neacşu E; Gangură M; Schindler AE; Stroe E; Anghel C; Panaitescu G
J Steroid Biochem; 1983 Apr; 18(4):459-63. PubMed ID: 6834830
[TBL] [Abstract][Full Text] [Related]
6. Association between estradiol, estrogen receptors, total lipids, triglycerides, and cholesterol in patients with benign and malignant breast tumors.
Mady EA
J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):323-8. PubMed ID: 11282289
[TBL] [Abstract][Full Text] [Related]
7. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
[TBL] [Abstract][Full Text] [Related]
8. Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels.
Geisler J; Helle H; Ekse D; Duong NK; Evans DB; Nordbø Y; Aas T; Lønning PE
Clin Cancer Res; 2008 Oct; 14(19):6330-5. PubMed ID: 18829517
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and tibolone metabolite levels in blood and breast tissue of postmenopausal women recently diagnosed with early-stage breast cancer and treated with tibolone or placebo for 14 days.
Kloosterboer HJ; Löfgren L; von Schoulz E; von Schoultz B; Verheul HA
Reprod Sci; 2007 Feb; 14(2):151-9. PubMed ID: 17636226
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease.
Reed MJ; Cheng RW; Noel CT; Dudley HA; James VH
Cancer Res; 1983 Aug; 43(8):3940-3. PubMed ID: 6683128
[TBL] [Abstract][Full Text] [Related]
12. Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients.
Geisler J; Haynes B; Anker G; Helle H; Ekse D; Dowsett M; Lønning PE
J Steroid Biochem Mol Biol; 2005 Sep; 96(5):415-22. PubMed ID: 16168635
[TBL] [Abstract][Full Text] [Related]
13. Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer.
Flågeng MH; Knappskog S; Gjerde J; Lønning PE; Mellgren G
PLoS One; 2015; 10(8):e0134351. PubMed ID: 26247365
[TBL] [Abstract][Full Text] [Related]
14. Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.
Abul-Hajj YJ
Steroids; 1979 Aug; 34(2):217-25. PubMed ID: 494363
[TBL] [Abstract][Full Text] [Related]
15. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
16. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
17. A relationship between estrogen sulfurylation and estrogen and progesterone receptor status in human mammary carcinoma.
Pewnim T; Adams JB; Ho KP
Cancer Res; 1980 Apr; 40(4):1360-2. PubMed ID: 6928401
[TBL] [Abstract][Full Text] [Related]
18. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue.
van Landeghem AA; Poortman J; Nabuurs M; Thijssen JH
Cancer Res; 1985 Jun; 45(6):2900-6. PubMed ID: 3986816
[TBL] [Abstract][Full Text] [Related]
19. Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels.
Geisler J; Haynes B; Ekse D; Dowsett M; Lønning PE
J Steroid Biochem Mol Biol; 2007 Apr; 104(1-2):27-34. PubMed ID: 17350249
[TBL] [Abstract][Full Text] [Related]
20. Effects of hormone therapy on estrogen synthesis from E1S in the mammary gland of postmenopausal women.
Stute P; Szuwart T; Schlueter M; Götte M; Packeisen J; Kiesel L
Maturitas; 2008 Feb; 59(2):163-73. PubMed ID: 18261865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
